Koss-Olinger Consulting’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $533K | Buy |
4,961
+15
| +0.3% | +$1.61K | 0.04% | 196 |
|
|
2025
Q1 | $499K | Buy |
+4,946
| New | +$499K | 0.04% | 200 |
|
|
2024
Q4 | – | Sell |
-4,946
| Closed | -$414K | – | 202 |
|
|
2024
Q3 | $414K | Hold |
4,946
| – | – | 0.04% | 184 |
|
|
2024
Q2 | $381K | Buy |
+4,946
| New | +$381K | 0.04% | 179 |
|
|
2024
Q1 | – | Sell |
-5,252
| Closed | -$304K | – | 86 |
|
|
2023
Q4 | $304K | Sell |
5,252
-74
| -1% | -$4.28K | 0.03% | 237 |
|
|
2023
Q3 | $281K | Buy |
5,326
+4
| +0.1% | +$211 | 0.04% | 197 |
|
|
2023
Q2 | $288K | Hold |
5,322
| – | – | 0.03% | 190 |
|
|
2023
Q1 | $266K | Buy |
5,322
+191
| +4% | +$9.55K | 0.03% | 189 |
|
|
2022
Q4 | $237K | Buy |
+5,131
| New | +$237K | 0.03% | 185 |
|
|
2021
Q4 | – | Sell |
-6,731
| Closed | -$292K | – | 221 |
|
|
2021
Q3 | $292K | Buy |
+6,731
| New | +$292K | 0.05% | 175 |
|